Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease

Parkinson’s disease, the second most common neurodegenerative disorder worldwide, is characterized by the accumulation of protein deposits in the dopaminergic neurons. These deposits are primarily composed of aggregated forms of α-Synuclein (α-Syn). Despite the extensive research on this disease, on...

Descripción completa

Detalles Bibliográficos
Autores principales: Peña-Díaz, Samuel, García-Pardo, Javier, Ventura, Salvador
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059018/
https://www.ncbi.nlm.nih.gov/pubmed/36986700
http://dx.doi.org/10.3390/pharmaceutics15030839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10059018/
https://www.ncbi.nlm.nih.gov/pubmed/36986700
http://dx.doi.org/10.3390/pharmaceutics15030839

Ejemplares similares